Norwalk health payments innovator files for $100M IPO
Alexander Soule
FacebookTwitterEmail
The headquarters office of Remedy Partners at 800 Connecticut Ave. in Norwalk, Conn.Alexander Soule / Hearst Connecticut Media
Nearly a decade after its launch and expansion under Obamacare, an innovative insurance company with its roots in Norwalk is going public.
Texas-based Signify Health has plans to raise $100 million selling shares to trade on the New York Stock Exchange.
In 2019, Signify Health spent $405 million to acquire Remedy Partners, which was created eight years earlier in Norwalk by Oxford Health Plans founder Steve Wiggins. His idea was to develop a new system for health insurance, with premiums and payments pegged to “episodes of care” covering the span of a patient’s treatment and recovery from an ailment.
Published: Dec 07, 2020
NEWTON, Mass., Dec. 7, 2020 /PRNewswire/ Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, today announced the appointment of Alan Muney, MD to its Board of Directors. Dr. Muney is currently a senior healthcare advisor for Pritzker Private Capital, Arsenal Capital, Bain Management Consulting, and NEA Venture Capital. I feel privileged to be involved with such a talented team dedicated to the mission of bringing a great technology to market to help chronically ill patients, said Dr. Muney.
Previously Dr. Muney served as Cigna s Chief Medical Officer and Executive Vice President of Total Health and Network. In his role as Chief Medical Officer, Dr. Muney was responsible for Cigna s clinical strategy and policy, health advocacy programs, coverage policy, and quality measurement and improvement. As lead for Total Health and Network, Dr. Muney was responsible for